Metabolomics Provides Novel Insights into Epilepsy Diagnosis and Treatment: A Review
- PMID: 35067830
- DOI: 10.1007/s11064-021-03510-y
Metabolomics Provides Novel Insights into Epilepsy Diagnosis and Treatment: A Review
Abstract
Epilepsy is one of the most common diseases of the central nervous system. The diagnosis of epilepsy mainly depends on electroencephalograms and symptomatology, while diagnostic biofluid markers are still lacking. In addition, approximately 30% of patients with epilepsy (PWE) show a poor response to the currently available anti-seizure medicines. An increasing number of studies have reported alterations in the blood, brain tissue, cerebrospinal fluid and urine metabolome in PWE and animal models of epilepsy. The aim of this review was to identify potential metabolic biomarkers and pathways that might facilitate diagnostic, therapeutic and prognostic determination in PWE and the understanding of the pathogenesis of the disease. The PubMed and Embase databases were searched for metabolomic studies of PWE and epileptic models published before December 2020. The study objectives, types of models and reported differentially altered metabolites were examined and compared. Pathway analyses were performed using MetaboAnalyst 5.0 online software. Thirty-five studies were included in this review. Metabolites such as glutamate, lactate and citrate were disturbed in both PWE and epileptic models, which might be potential biomarkers of epilepsy. Metabolic pathways including alanine, aspartate and glutamate metabolism; glycine, serine and threonine metabolism; glycerophospholipid metabolism; glyoxylate and dicarboxylate metabolism; and arginine and proline metabolism were involved in epilepsy. These pathways might play important roles in the pathogenesis of the disease. This review summarizes metabolites and metabolic pathways related to epilepsy and provides a novel perspective for the identification of potential biomarkers and therapeutic targets for epilepsy.
Keywords: Biomarker; Epilepsy; Metabolic pathway; Metabolomics; Treatment.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Metabolomics facilitates the discovery of metabolic profiles and pathways for myopia: A systematic review.Eye (Lond). 2023 Mar;37(4):670-677. doi: 10.1038/s41433-022-02019-0. Epub 2022 Mar 24. Eye (Lond). 2023. PMID: 35322213 Free PMC article.
-
Metabolomics facilitates the discovery of metabolic biomarkers and pathways for ischemic stroke: a systematic review.Metabolomics. 2019 Nov 21;15(12):152. doi: 10.1007/s11306-019-1615-1. Metabolomics. 2019. PMID: 31754808
-
Quality markers of animal medicinal materials: Correlative analysis of musk reveals distinct metabolic changes induced by multiple factors.Phytomedicine. 2018 May 15;44:258-269. doi: 10.1016/j.phymed.2018.03.008. Epub 2018 Mar 6. Phytomedicine. 2018. PMID: 29551642
-
Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF/MS-based untargeted metabolomics study.Biochem Pharmacol. 2021 Jan;183:114299. doi: 10.1016/j.bcp.2020.114299. Epub 2020 Oct 24. Biochem Pharmacol. 2021. PMID: 33148504
-
Metabolomics in Diabetic Retinopathy: A Systematic Review.Invest Ophthalmol Vis Sci. 2021 Aug 2;62(10):4. doi: 10.1167/iovs.62.10.4. Invest Ophthalmol Vis Sci. 2021. PMID: 34347011 Free PMC article.
Cited by
-
Statistical methods and resources for biomarker discovery using metabolomics.BMC Bioinformatics. 2023 Jun 15;24(1):250. doi: 10.1186/s12859-023-05383-0. BMC Bioinformatics. 2023. PMID: 37322419 Free PMC article. Review.
-
Plasma metabolome reveals altered oxidative stress, inflammation, and amino acid metabolism in dogs with idiopathic epilepsy.Epilepsia. 2025 Apr;66(4):1315-1328. doi: 10.1111/epi.18256. Epub 2025 Jan 13. Epilepsia. 2025. PMID: 39804158 Free PMC article.
-
Unveiling the influence of caffeine on topiramate: metabolomic marker analysis using liquid chromatography-mass spectrometry.Front Mol Biosci. 2025 Jun 17;12:1549993. doi: 10.3389/fmolb.2025.1549993. eCollection 2025. Front Mol Biosci. 2025. PMID: 40600026 Free PMC article.
-
Diet-derived circulating antioxidants and risk of epilepsy: A study combining metabolomics and mendelian randomization.Heliyon. 2024 Feb 29;10(5):e26813. doi: 10.1016/j.heliyon.2024.e26813. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38463786 Free PMC article.
-
The dysregulation and regulatory mechanism of long non-coding RNA LBX2-AS1 in children with epilepsy.Ital J Pediatr. 2025 Jun 15;51(1):189. doi: 10.1186/s13052-025-02045-0. Ital J Pediatr. 2025. PMID: 40518534 Free PMC article.
References
-
- Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, Engel J Jr, Forsgren L, French JA, Glynn M, Hesdorffer DC, Lee BI, Mathern GW, Moshé SL, Perucca E, Scheffer IE, Tomson T, Watanabe M, Wiebe S (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55:475–482 - PubMed
-
- Asadi-Pooya AA, Sperling MR (2015) Epidemiology of psychogenic nonepileptic seizures. Epilepsy Behav 46:60–65 - PubMed
-
- Montini A, Loddo G, Baldelli L, Cilea R, Provini F (2021) Sleep-related hypermotor epilepsy vs disorders of arousal in adults: a step-wise approach to diagnosis. Chest 160:319–329 - PubMed
-
- Wang YQ, Wen Y, Wang MM, Zhang YW, Fang ZX (2021) Prolactin levels as a criterion to differentiate between psychogenic non-epileptic seizures and epileptic seizures: A systematic review. Epilepsy Res 169:106508 - PubMed
-
- Téllez-Zenteno JF, Hernández-Ronquillo L, Buckley S, Zahagun R, Rizvi S (2014) A validation of the new definition of drug-resistant epilepsy by the International League Against Epilepsy. Epilepsia 55:829–834 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical